Profil bibliographique

Nisreen Khalid Aref Albezrah

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

30Publications signalées

286Citations signalées

1Affiliations récentes

Institutions déclarées

Domaines associés

Advancements in Transdermal Drug DeliverySynthesis and biological activityAdvanced Drug Delivery SystemsNatural Antidiabetic Agents StudiesPhytochemicals and Antioxidant Activities

Publications récentes

2026 articleOpenAlex

Design and optimization of isoxsuprine-loaded novasomes for the attenuation of coronary artery disease in rats

Amr Gamal Fouad, Amany Belal, Suhaib Mohammadmustafa Bukhari, Nisreen Khalid Aref Albezrah et autres

0 citationsNaunyn-Schmiedeberg s Archives of Pharmacology

2026 articleOpenAlex

Design, optimization, and in vivo assessment of in situ pH-sensitive quercetin transbilosomes for the treatment of diabetes mellitus-associated heart failure

Wenxue Jin, Marwa H. Elkarmalawy, Amr Gamal Fouad, Amany Belal et autres

1 citationJournal of drug targeting

2025 articleOpenAlex

Mitigating doxorubicin-induced toxicity in breast cancer treatment with in situ pH-sensitive carvedilol-loaded transbilosomes: in vitro and in vivo characterization

Tamer Mohamed Mahmoud, Mohammed Ayad Alboreadi, Fatma I. Abo El‐Ela, Amr Gamal Fouad et autres

0 citationsJournal of drug targeting

2025 articleOpenAlex

Improving the therapeutic efficacy and bioavailability of carvedilol for control of diabetes-associated heart failure: in vitro and in vivo characterisation

Tamer Mohamed Mahmoud, Mohammed Ayad Alboreadi, Amr Gamal Fouad, Nada H. Mohammed et autres

0 citationsJournal of drug targeting

2025 articleOpenAlex

Improving the bioavailability and therapeutic efficacy of valsartan for the control of cardiotoxicity-associated breast cancer

Mary Eskander Attia, Fatma I. Abo El‐Ela, Saad M. Wali, Amr Gamal Fouad et autres

0 citationsJournal of drug targeting

2025 articleOpenAlex

Improving the efficacy and targeting of carvedilol for the management of diabetes-accelerated atherosclerosis: An in vitro and in vivo assessment

Marwa M. Nagib, Amr Gamal Fouad, Amany Belal, Fahad H. Baali et autres

0 citationsEuropean Journal of Pharmacology

2025 articleOpenAlex

Design and optimization of carvedilol-loaded transbilosomes for the control of diabetic high-fat diet-induced atherosclerosis in rats

Marwa M. Nagib, Amr Gamal Fouad, Amany Belal, Fahad H. Baali et autres

0 citationsJournal of Pharmacy and Pharmacology

Accès ouvert 2025 articleOpenAlex

Innovative Azo Disperse Dyes Containing a Hydrazide–Hydrazone Moiety: Design, DFT Calculations, Antimicrobial and Antibiofilm Activities, and Dyeing Performance on Polyester Fabrics

Walid E. Elgammal, Ali A. Ali, Gameel A. M. Elhagali, Mostafa A. Ismail et autres

8 citationsACS Omega

Accès ouvert 2025 articleOpenAlex

Novel Sulfonamide Derivatives as Anticancer Agents, VEGFR-2 Inhibitors, and Apoptosis Triggers: Design, Synthesis, and Computational Studies

Shatha Hallal Al-Ziyadi, Ahmed H. Halawa, Amany Belal, Nisreen Khalid Aref Albezrah et autres

12 citationsACS Omega

2025 articleOpenAlex

Efficacy and safety of valsartan–novasomes in the mitigation of atherosclerosis-associated diabetes mellitus: in vitro and in vivo assessment

Tamer Mohamed Mahmoud, Mohammed Ayad Alboreadi, Amr Gamal Fouad, Amany Belal et autres

1 citationJournal of drug targeting

2025 articleOpenAlex

Evaluating the efficacy of nintedanib-invasomes as a therapy for non-small cell lung cancer

Tamer Mohamed Mahmoud, Mohamed H. Abdel‐Rahman, Mary Eskander Attia, Marwa M. Nagib et autres

1 citationEuropean Journal of Pharmaceutics and Biopharmaceutics

2025 articleOpenAlex

Fabrication and optimization of valsartan-loaded transbilosomes for management of diabetes mellitus-accelerated stroke

Amr Gamal Fouad, Amany Belal, Mohamed A. M. Ali, Nisreen Khalid Aref Albezrah et autres

0 citationsJournal of Pharmaceutical Sciences

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.